JP2025509278A5 - - Google Patents
Info
- Publication number
- JP2025509278A5 JP2025509278A5 JP2024553365A JP2024553365A JP2025509278A5 JP 2025509278 A5 JP2025509278 A5 JP 2025509278A5 JP 2024553365 A JP2024553365 A JP 2024553365A JP 2024553365 A JP2024553365 A JP 2024553365A JP 2025509278 A5 JP2025509278 A5 JP 2025509278A5
- Authority
- JP
- Japan
- Prior art keywords
- wee1 inhibitor
- day
- etoposide
- treatment
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22160556 | 2022-03-07 | ||
| EP22160556.1 | 2022-03-07 | ||
| PCT/EP2023/055751 WO2023170065A1 (en) | 2022-03-07 | 2023-03-07 | Methods of treating small cell lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509278A JP2025509278A (ja) | 2025-04-11 |
| JP2025509278A5 true JP2025509278A5 (https=) | 2026-03-16 |
Family
ID=80682926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553365A Pending JP2025509278A (ja) | 2022-03-07 | 2023-03-07 | 小細胞肺癌を治療する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20260027117A1 (https=) |
| EP (1) | EP4489756A1 (https=) |
| JP (1) | JP2025509278A (https=) |
| KR (1) | KR20240158972A (https=) |
| CN (1) | CN118843466A (https=) |
| AR (1) | AR128711A1 (https=) |
| AU (1) | AU2023232376A1 (https=) |
| CA (1) | CA3253688A1 (https=) |
| IL (1) | IL315441A (https=) |
| MX (1) | MX2024010900A (https=) |
| TW (1) | TW202337469A (https=) |
| WO (1) | WO2023170065A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025186213A1 (en) * | 2024-03-04 | 2025-09-12 | Debiopharm International S.A. | Combination of a wee1 inhibitor and a topoisomerase 1 inhibitor |
| CN118581045A (zh) * | 2024-07-29 | 2024-09-03 | 云南省肿瘤医院(昆明医科大学第三附属医院) | 一株多突变的人小细胞肺癌淋巴结转移原代细胞系及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5129812B2 (ja) | 2007-06-15 | 2013-01-30 | Ｍｓｄ株式会社 | ビシクロアニリン誘導体 |
| MX2014010176A (es) | 2012-02-23 | 2014-11-10 | Abbvie Inc | Inhibidores de cinasas de piridopirimidinona. |
| US10703759B2 (en) | 2016-11-16 | 2020-07-07 | Impact Therapeutics, Inc | 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones |
| GB201703881D0 (en) * | 2017-03-10 | 2017-04-26 | Almac Discovery Ltd | Pharmaceutical compounds |
| WO2022155202A1 (en) | 2021-01-13 | 2022-07-21 | Schrödinger, Inc. | Fused heterocycles and uses of same |
| WO2022188802A1 (en) * | 2021-03-10 | 2022-09-15 | Impact Therapeutics (Shanghai) , Inc | Use of wee1 kinase inhibitors in the treatment of cancer |
| CN117794932A (zh) | 2021-06-04 | 2024-03-29 | 阿普里治疗股份有限公司 | 可用作wee1激酶抑制剂的吡啶并嘧啶衍生物 |
| WO2023093840A1 (en) * | 2021-11-26 | 2023-06-01 | Impact Therapeutics (Shanghai) , Inc | Use of wee1 kinase inhibitors in the treatment of cancer |
-
2023
- 2023-03-07 CA CA3253688A patent/CA3253688A1/en active Pending
- 2023-03-07 AR ARP230100553A patent/AR128711A1/es unknown
- 2023-03-07 TW TW112108359A patent/TW202337469A/zh unknown
- 2023-03-07 WO PCT/EP2023/055751 patent/WO2023170065A1/en not_active Ceased
- 2023-03-07 MX MX2024010900A patent/MX2024010900A/es unknown
- 2023-03-07 AU AU2023232376A patent/AU2023232376A1/en active Pending
- 2023-03-07 EP EP23716186.4A patent/EP4489756A1/en active Pending
- 2023-03-07 JP JP2024553365A patent/JP2025509278A/ja active Pending
- 2023-03-07 US US18/844,741 patent/US20260027117A1/en active Pending
- 2023-03-07 KR KR1020247033425A patent/KR20240158972A/ko active Pending
- 2023-03-07 CN CN202380026002.5A patent/CN118843466A/zh active Pending
- 2023-03-07 IL IL315441A patent/IL315441A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023088944A5 (https=) | ||
| JP2022121594A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| JP2022537551A5 (https=) | ||
| JP2024133475A5 (https=) | ||
| JP2021155426A5 (https=) | ||
| JP2025509278A5 (https=) | ||
| JP2019515884A5 (https=) | ||
| IL178745A (en) | Use of 4- (amino) -2 (2, 6-dioxo (3-piperidyl)) -isoindoline -1, 3-discussion of preparation of a medical vaccine for the treatment of myeloma | |
| JP2009514874A5 (https=) | ||
| JP2018523689A5 (https=) | ||
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| JP2019515908A5 (https=) | ||
| JP2005008534A (ja) | 抗癌剤及び癌の治療方法 | |
| JP2023550149A5 (https=) | ||
| JP2024515829A5 (https=) | ||
| JP2024502446A5 (https=) | ||
| JP2021509395A5 (https=) | ||
| JP2022532766A5 (https=) | ||
| JP2019218379A5 (https=) | ||
| JP2024531188A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| JP2023011549A5 (https=) | ||
| JP2024540439A5 (https=) |